Ana Mihalcea, MD & Karen Kingston - AI magnetic Hydrogel Bioweapon & Nanotechnology in C19 shots

Karen Kingston’s bio:
As a strategic consultant and biotech analyst, Karen Kingston was hired by her clients to ensure that expert doctors (key opinion leaders), attorneys, corporate marketers, board members, and investors are all on the same page in regards to what is being said about a product and a disease state, what their product can do and cannot do, who to target as B2B or B2C customers, how to target customers and with what messages, and to make sure everything was med-legal compliant. She has been brought in to turn around situations where clients were looking to dissolve strategic business units ranging from $200mm - $350mm because they were facing up to a billion-dollar fine or simply losing too much revenue. One turnaround resulted in a $1B+ exit acquisition strategy to Mallinkrodt.
Her clients have included Pfizer, Medtronic, Allergan, Johnson & Johnson, Thermo Fisher Scientific, and many smaller companies.